Urology News

Main Category: Erectile Dysfunction / Premature Ejaculation Also Included In: Urology / Nephrology ; Men's health ; Clinical Trials / Drug Trials Article Date: 26 Jul 2008 - 1:00 PDT A study published in the ...

An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday.

Men over 40 may want to avoid iced tea and start hitting the lemonade if they wish to lower their risk of kidney stones, according to experts.

Main Category: Urology / Nephrology Also Included In: Cancer / Oncology Article Date: 24 Jul 2008 UroToday.com - In this study of 58 laparoscopic cryoablations, 20 percutaneous cryoablations, and 15 ...

Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology Article Date: 24 Jul 2008 UroToday.com - In the online edition of European Urology , Dr.

There may be a hidden health danger in a popular summertime beverage. Doctors at Loyola University Hospital in Maywood say iced tea contains high levels of a chemical that leads to kidney stones, a common ...

Main Category: Urology / Nephrology Also Included In: Pediatrics / Children's Health Article Date: 24 Jul 2008 UroToday.com - Dr.

Main Category: Urology / Nephrology Also Included In: Clinical Trials / Drug Trials Article Date: 24 Jul 2008 Everolimus, also called Certican, can stall progression of for patients with renal cell carcinoma ...

Mark Mulac was once an "avid lover" of iced tea, downing up to six glasses a day of the popular summertime thirst-quencher. "I was a junkie on a bender.

An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday.

Gundersen Lutheran soon will be using the newest and most advanced robotic surgical assistant technology to provide the least invasive surgery for prostate and gynecological cancers.

An experimental prostate cancer drug which looks to add years of life to men with advanced disease has been heralded as "sensational" by Australian experts.

AUSTIN, Texas - HealthTronics, Inc. , a leading provider of urology services and products, today announced that it has acquired UroPath, LLC for $7.5 million.

Main Category: Urology / Nephrology Also Included In: Cancer / Oncology Article Date: 19 Jul 2008 UroToday.com - Muscle infiltrating bladder cancer is a life-threatening disease.

Main Category: Transplants / Organ Donations Also Included In: Urology / Nephrology Article Date: 16 Jul 2008 A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for ...

Senate Bill Would Relax U.S. Ban on Visitors With HIV E. coli Outbreak in Beef May Have Widened to 5 States Here are some of the latest health and medical news developments, compiled by editors of HealthDay: A ...

Main Category: Urology / Nephrology Also Included In: Pediatrics / Children's Health Article Date: 18 Jul 2008 UroToday.com - A study out of the Mayo Clinic by Dr.

Black men with early prostate cancer may be less likely to receive aggressive treatment than their white counterparts, a small study has found.

A group of international experts in urology, gastroenterology, internal medicine, rheumatology, epidemiology, behavioral science and other disciplines convened with a goal of re-characterizing the two most ...

Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 17 Jul 2008 - 1:00 PDT Dendreon Corporation ...